18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer

@article{Duch200918FFDGPF,
  title={18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer},
  author={Joan Duch and David Dom{\'i}nguez Fuster and Montserrat Palma i Mu{\~n}oz and Pedro Luis S{\'a}nchez Fern{\'a}ndez and Pilar Paredes and Montserrat Deulofeu i Fontanillas and F Alfan Guzman and Sebasti{\'a} Rub{\'i} and Francisco Lome{\~n}a and Françesca Pons},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2009},
  volume={36},
  pages={1551-1557}
}
PurposeThe aim of this study was to prospectively evaluate 18F-FDG PET/CT in predicting response to neoadjuvant chemotherapy in large primary breast cancer.MethodsFifty consecutive patients underwent PET/CT at baseline and after the second cycle. Baseline MRI was performed to establish tumour size. All findings were confirmed by histopathological analysis. Changes in maximum standardized uptake value (SUVmax) between baseline study and after two cycles of neoadjuvant chemotherapy (epirubicin… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 35 CITATIONS

Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.

  • Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • 2017
VIEW 2 EXCERPTS
CITES BACKGROUND

18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 38 REFERENCES

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy

  • European Journal of Nuclear Medicine and Molecular Imaging
  • 2007
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Predictive value of [18F] FDG PET for pathological response of breast cancer to neoadjuvant chemotherapy

SJ Kim, SK Kim, ES Lee, J Ro, S. Kang
  • Ann Oncol 2004;15:1352–7
  • 2009
VIEW 1 EXCERPT

( 18 ) F - FDG PET / CT semiology ( in Spanish )

M Coronado, RM Couto, S Rodado, LM Martín
  • Rev Esp Med Nucl
  • 2008

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2008
VIEW 1 EXCERPT

Update of evidence in chemotherapy for breast cancer

  • International Journal of Clinical Oncology
  • 2007
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…